To evaluate diagnostic accuracy of quantitative fetal fibronectin (qfFN) test in predicting preterm birth (PTB) risk <34 weeks' gestation or within 14 days from testing. We explored the predictive potential of the test in five-predefined PTB risk categories based on predefined qfFN thresholds (<10, 10-49, 50-199, 200-499 and ≥500 ng/mL)
Objectives: Spontaneous preterm birth is a leading cause of neonatal death. Fetal fibronectin (fFN) ...
Objective: This study was conducted to evaluate the usefulness of testing for fetal fibronectin (fFN...
Objective: To determine if quantitative fetal fibronectin (qFFN) in addition to transvaginal ultraso...
To evaluate diagnostic accuracy of quantitative fetal fibronectin (qfFN) test in predicting preterm ...
none17noOBJECTIVE: To evaluate diagnostic accuracy of quantitative fetal fibronectin (qfFN) test i...
Aim: To evaluate the clinical application of the new Hologic quantitative foetal fibronectin (qfFN) ...
Objective To determine whether the quantitative value of fetal fibronectin (fFN) can predict preterm...
Background: Preterm birth defined as birth before 37 weeks of gestation is a significant public heal...
Background: Recent data suggest that quantitative measurements of fetal fibronectin can be used accu...
Accurate prediction of preterm birth is a big clinical challenge in obstetrics. Most of the women pr...
Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronect...
INTRODUCTION: Fetal fibronectin (fFN) is a validated test for assessing risk of preterm birth for wo...
Context: Preterm births occur in 11% of all births worldwide, but account for more than 85% of perin...
Preterm delivery is the leading cause of neonatal mortality. One of the best predictors to assess th...
INTRODUCTION: Fetal fibronectin (fFN) is a validated test for assessing risk of preterm birth for wo...
Objectives: Spontaneous preterm birth is a leading cause of neonatal death. Fetal fibronectin (fFN) ...
Objective: This study was conducted to evaluate the usefulness of testing for fetal fibronectin (fFN...
Objective: To determine if quantitative fetal fibronectin (qFFN) in addition to transvaginal ultraso...
To evaluate diagnostic accuracy of quantitative fetal fibronectin (qfFN) test in predicting preterm ...
none17noOBJECTIVE: To evaluate diagnostic accuracy of quantitative fetal fibronectin (qfFN) test i...
Aim: To evaluate the clinical application of the new Hologic quantitative foetal fibronectin (qfFN) ...
Objective To determine whether the quantitative value of fetal fibronectin (fFN) can predict preterm...
Background: Preterm birth defined as birth before 37 weeks of gestation is a significant public heal...
Background: Recent data suggest that quantitative measurements of fetal fibronectin can be used accu...
Accurate prediction of preterm birth is a big clinical challenge in obstetrics. Most of the women pr...
Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronect...
INTRODUCTION: Fetal fibronectin (fFN) is a validated test for assessing risk of preterm birth for wo...
Context: Preterm births occur in 11% of all births worldwide, but account for more than 85% of perin...
Preterm delivery is the leading cause of neonatal mortality. One of the best predictors to assess th...
INTRODUCTION: Fetal fibronectin (fFN) is a validated test for assessing risk of preterm birth for wo...
Objectives: Spontaneous preterm birth is a leading cause of neonatal death. Fetal fibronectin (fFN) ...
Objective: This study was conducted to evaluate the usefulness of testing for fetal fibronectin (fFN...
Objective: To determine if quantitative fetal fibronectin (qFFN) in addition to transvaginal ultraso...